Načítá se...
Improved biomarker performance for the detection of hepatocellular carcinoma by inclusion of clinical parameters
We have previously identified several biomarkers of hepatocellular carcinoma (HCC). The levels of three of these biomarkers were analyzed individually and in combination with the currently used marker, alpha fetoprotein (AFP), for the ability to distinguish between a diagnosis of cirrhosis (n=113) a...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3845221/ https://ncbi.nlm.nih.gov/pubmed/24307972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1109/BIBM.2012.6392612 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|